TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $454,000 | +4.8% | 31,697 | -0.2% | 0.17% | +5.7% |
Q4 2021 | $433,000 | -16.7% | 31,767 | 0.0% | 0.16% | -25.8% |
Q3 2021 | $520,000 | -2.8% | 31,767 | 0.0% | 0.21% | -2.7% |
Q2 2021 | $535,000 | -12.3% | 31,767 | -4.9% | 0.22% | -19.5% |
Q1 2021 | $610,000 | -9.2% | 33,408 | -9.5% | 0.27% | -15.8% |
Q4 2020 | $672,000 | +2.1% | 36,931 | +0.2% | 0.32% | -10.0% |
Q3 2020 | $658,000 | -0.5% | 36,861 | 0.0% | 0.36% | -6.3% |
Q2 2020 | $661,000 | +18.0% | 36,861 | 0.0% | 0.38% | -3.5% |
Q1 2020 | $560,000 | -23.0% | 36,861 | 0.0% | 0.40% | -0.8% |
Q4 2019 | $727,000 | +14.1% | 36,861 | -0.5% | 0.40% | +6.4% |
Q3 2019 | $637,000 | -3.2% | 37,029 | -0.4% | 0.38% | -6.0% |
Q2 2019 | $658,000 | -13.2% | 37,196 | 0.0% | 0.40% | -15.3% |
Q1 2019 | $758,000 | – | 37,196 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |